Financials • Life Insurance
$135.97 ▲ +1.47
(+1.09%)
MKT CAP: $9.21B • VOL: 673.6K
52W L $90 52W H $141
JXN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.68B | $3.27B | $3.08B |
| YoY Revenue Growth % | +104.3% | +6.1% | — |
| Gross Profit | $2.94B | $1.44B | $1.36B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$20.1M | $1.06B | $1.06B |
| Operating Margin % | -0.3% | 32.5% | 34.4% |
| Net Income (GAAP) | -$17.0M | $902.0M | $899.0M |
| EBITDA (Normalized) | $220.5M | $1.18B | $1.17B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.76B | $5.79B | $5.31B |
| Capital Expenditures (CapEx) | $300.7M | $147.2M | $138.7M |
| Free Cash Flow (FCF) | $5.46B | $5.65B | $5.17B |
| FCF Margin % | 81.7% | 172.6% | 167.7% |
| Return on Invested Capital (ROIC %) | 0.0% | 0.5% | 27.4% |
| Cash & Short-Term Equivalents | $5.70B | $3.77B | $557.1M |
| Total Debt (Short + Long Term) | $154.01B | $147.81B | $1.19B |
| Total Stockholders' Equity | $9.95B | $9.76B | $2.43B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR JXN.